Coherus Oncology Inc (CHRS)

Investing Cash Flow

$20.88M

TTM · Period ending: · USD

CHRS logo

CHRS Investing Cash Flow

Latest reported$20.88M
CHRS TTM Cash from Investing (-$373.00K → $20.88M)
High-resolution chart · PNG

CHRS investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
20,876,000
423,228,000
375,087,000
377,383,000
445,054,000
10,072,000
230,321,000
266,066,000
316,168,000
329,877,000
144,640,000
-20,461,000
-71,464,000
-113,709,000
-166,850,000
70,538,000
86,985,000
111,450,000
-138,410,000
-35,844,000
-35,427,000
-298,260,000
-14,401,000
-230,519,000
-247,215,000
851,000
-12,732,000
9,116,000
22,216,000
-3,206,000
-1,188,000
-2,583,000
13,312,000
33,980,000
-4,417,000
-22,374,000
-51,580,000
-55,945,000
-6,515,000
-4,393,000
-7,077,000
-7,784,000
-6,949,000
-6,004,000
-3,627,000
-3,912,000
-525,000
-174,000
580,000
1,869,000
-373,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.